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Background: Heart rate reduction in patients with stable angina by combination of ivabradine with beta-blockers provides additional anti-
ischemic efficacy, in comparison with uptitration of beta-blockers.
Methods: In single-blind parallel-group study 30 patients with a first anterior myocardial infarction and early ejection fraction (EF) 30-45 %, sinus 
rhythm > 80 bpm, Killip class I-II were randomized. Patients in group 1 (n=18) from day 1 received metoprolol uptitrated by day 5 to 25 mg bid 
and then ivabradine 2.5 mg bid uptitrated to 7.5 mg bid. Patients in group 2 (n=12) received metoprolol uptitrated to 75 mg. Besides end-diastolic 
index (EDI) and EF on day 1 and 25, early mitral annulus velocity (E’) and early mitral filling velocity (E) were estimated by echo-Dopper at day 5 and 
25, serum N-Terminal pro Atrial Natriuretic Peptide (NT-proANP) at day 2 and 25.
Results: Resting heart rate was similar in both groups (at day 5 - 68.6 ± 2.0 vs. 67.3 ± 1.2 bpm, at day 25 - 60.9 ± 1.6 vs. 61.7 ± 1.1 bpm, all p > 
0.05). Groups didn’t differ in basal EDI, EF, E/E’ and serum NT-pro-ANP (72.4 ± 1.4 vs. 72.8 ± 1.5 ml/m2, 39.2 ± 1.5 vs. 38.9 ± 1.8 %, 8.59 ± 0.17 
vs. 8.93 ± 0.18, 3495.5 ± 305.1 vs. 3487.2 ± 281.3 pmol/l, respectively, all p > 0.05). At day 25 compared to basal levels in group 1 EDI increased 
to 76.1 ± 1.4 ml/m2, EF - to 46.3 ± 1.2 %, E/E’ lowered to 8.08 ± 0.16 (p < 0.05) and NT-pro-ANP decreased to 2281.3 ± 198.4 pmol/l (p < 0.01), 
while all this indices except EDI that increased to 81.1 ± 1.4 ml/m2 (p < 0.01) didn’t changed in group 2 (39.9 ± 1.4 %, 8.77 ± 0.17 and 3572.4 ± 
207.1 pmol/l, respectively, p > 0.05, compared to basal values, and p < 0.01, p < 0.05 and p < 0.01 respectively, compared to group 1 at day 25).
Conclusions: In patients with anterior myocardial infarction and early left ventricular systolic dysfunction addition of ivabradine to metoprolol, in 
comparison with uptitration of metoprolol was associated with improvement of systolic and diastolic left ventricular function and decrease of serum 
NT-pro-ANP by day 25.
